Across 2025, the Alliance for Connected Care continued to be the leading national voice for virtual care, driving concrete policy wins, mobilizing Congress at critical moments, and protecting patient access across Medicare and the commercial markets. In a year defined by policy uncertainty and high-stakes deadlines, the Alliance for Connected Care didn’t just respond [...]
JAMA Network Open: Navigating Remote Blood Pressure Monitoring—The Devil Is in the Details In this invited commentary, authors respond to Mehta et al, which compared the effectiveness of remote patient monitoring of blood pressure and medication adherence reminders. The authors applauded the study’s strengths, but emphasized the importance of adding implementation context. The authors [...]
Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup In the face of an overwhelming overdose crisis, largely driven by the rise in the synthetic opioid fentanyl, telehealth for MOUD treatment promises to benefit many people. Currently, prescription volumes for MOUD are low and certain under-resourced communities experience significant [...]
Telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation (RIN: 1117-AB40)Drug Enforcement Administration Notice of Proposed RulemakingPublic comments due March 31, 2023DEA Resources: Rule Text Highlights for Medical PractitionersDEA Summary ChartSee companion buprenorphine rule summary hereProposed Rule OverviewThe Ryan Haight Act of 2008 directed the [...]
The Drug Enforcement Administration (DEA) released its Notice of Proposed Rulemaking (NPRM) on buprenorphine via telemedicine encounter, a summary, and highlights for medical practitioners. The proposed rule amends the DEA’s regulations, in concert with the Department of Health and Human Services (HHS), on the circumstances under which individual practitioners are authorized to prescribe schedule [...]
A Nationwide Telehealth Heart Failure Program: Can Remote Patient Monitoring and Guideline Directed Treatment Protocols Help Bridge the Gaps in Heart Failure Management?
Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial Background: The randomized INH (Interdisciplinary Network Heart Failure) trial (N = 715) reported that 6 months' remote patient management (RPM) (HeartNetCare-HF) did not reduce the primary outcome (time to all-cause death/rehospitalization) vs usual care (UC) in patients discharged [...]
Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) Background: Guidelines recommend early initiation of multiple guideline-directed medical therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart failure and reduced ejection fraction. Understanding GDMT use is critical to improving clinical practice. Objectives: This study sought to describe GDMT use in Japan, Sweden, and [...]
Mount Sinai Health tackles digital health inequity with robust RPM program
Diabetes Technology: Standards of Care in Diabetes—2023 The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary [...]